India Glycols Limited: Updates
Updates - India Glycols Limited has informed the Exchange regarding 'Material Update in connection with Ennature Bio Pharma Limited with reference toObservation letter no. NSE/LIST/48932 dated 17th November, 2025 and no.DCS/AMAL/TS/R37/3905/2025-26 dated 19th November, 2025 ("Observation Letters"), issuedby the National Stock Exchange of India Limited and BSE Limited (collectively the "StockExchanges"), respectively, received in relation to the Scheme of Arrangement.'.
SectorPharma & Healthcare
Sources
- NSE filing - India Glycols Limited · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026